A77-25978-23029
4 vaccinations
5 coded responses
47 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 220 / VA
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
FGH-37610-67062
Child or adolescent in my care · Male · 2022-10-21
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy, Sensitisation — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Mild lymph node swelling/sensitivity in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-20
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at site of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-27
Survey response — day 7, dose 1MedDRA: Axillary pain — Feeling: GoodFree text: Small amount of intermittent pain in armpit, as beforeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Poor · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Increased heart rate 70s- 80s restingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-19
Dose 3 — Pfizer-BioNTech
- 2021-10-22
- 2021-10-23
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2022-01-18
- 2022-04-19
- 2022-10-19
-
2022-10-21
Dose 4 — Moderna
- 2022-10-21
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2022-10-23
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
-
2022-10-28
Health check-in — day 7, dose 4Feeling: Good · Headache · Be unable to work or attend schoolAdult check-in
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-26
- 2022-12-02
- 2023-01-20
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
| 4 | 2022-10-21 | Moderna | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild lymph node swelling/sensitivity in armpit
Systemic reaction (other): Bruise at site of injection
Release 1 — day 7, dose 1
Systemic reaction (other): Small amount of intermittent pain in armpit, as before
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Increased heart rate 70s- 80s resting
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Sensitisation | ✓ | ✓ | ✓ |
| SRO | Sensitive skin | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release